General Movements pada Bayi dengan Riwayat Hiperbilirubinemia

Patricia A. Pattinama, Alifiani Hikmah Putranti, Gatot Irawan Sarosa

Sari


Latar belakang. Deteksi dini gangguan perkembangan neurologis pada bayi muda sulit dilakukan.
Hiperilirubinemia merupakan salah satu penyebab terjadinya gangguan perkembangan pada anak.
Pemeriksaan kualitas general movements(GMs) pada usia fidgety(3 bulan) memiliki nilai prediksi terhadap
gangguan perkembangan.
Tujuan.Menilai pengaruh hiperbilrubinemia terhadap terjadinya abnormal GMs.
Metode.Penelitian kohort dilanjutkan dengan nested case controlpada 44 bayi yang lahir di RSUP Dr.Kariadi,
Semarang pada September 2009 sampai dengan Februari 2010. Subyek penelitian terdiri dari kelompok
I 22 bayi dengan kadar BIS (bilirubin indirek serum) >12 mg/dl dan kelompok II 22 bayi dengan kadar
BIS <12 mg/dl, pada kedua kelompok dilakukan pemeriksaan GMs dengan rekaman video menggunakan
standarisasi metode Prechtl pada usia 3 bulan. Analisis hasil rekaman dilakukan oleh ahli. Hasil dari kelompok
normal dan kelompok abnormal, dilakukan nested case controlGMs abnormal adalah kelompok kasus
dan kelompok kontrol GMs normal berdasarkan skala Likert. Abnormal GMs apabila skor d5. Diteliti
hubungan hiperbilirubinemia dengan GMs abnormal. Uji statistik dengan chi-square, Receiver operating
curve(ROC), dan multivariat regresi logistik.
Hasil. Rerata kadar BIS pada kelompok I 15,0±3,43 mg/dL dan rerata kadar BIS pada kelompok II 8,5±1,68
mg/dL. Pada kedua kelompok terdapat neonatus dengan GMs normal dan abnormal. Rerata kadar BIS pada
kelompok abnormal GMs (kelompok kasus) 15,6±4,18 mg/dL, sedangkan kelompok kontrol 9,8±2,63 mg/dL
dengan p<0,001. Analisis kurva ROC menunjukkan luas area dibawah kurva ROC untuk kadar BIS 0,92. Kadar
BIS neonatal dapat digunakan sebagai prediktor GMs abnormal dengancut-off point BIS 12,67 mg/dL. 

Kesimpulan.Kadar BIS neonatal t12 mg/dL dapat digunakan sebagai prediktor GMs abnormal.


Kata Kunci


hiperbilirubinemia; general movements(GMs)

Teks Lengkap:

PDF

Referensi


Hadders-Algra M. Evaluation of motor function in

young infants by means of the assessments of general

Movements: a review. Ped Phys Ther 2001;13:7-36.

Hadders-Algra M, Klip van den Nieuwendijk AWJ, Martijn A, Van Eykern LA. Assesment of general movements:

toward better understanding of a sensitive method to

evaluate brain functionin in young infants. Dev Med

Child Neurol 1997;39:88-98.

Prechtl HFR.General movements assesment as a method

of developmental neurology : new paradigmas and their

consequences. Dev Med Child Neurol 2001;43:836-42.

Prechtl HFR.Qualitative changes of spontaneus

movements in fetus and preterm infants are a marker of

neurological disfunction. Early Hum Dev 1990;23:151-9.

Hadders-Algra M, Prechtl HFR.Developmental course of

general movements in early infancy, I: descriptive analysis

of change in form. Early Hum Dev 1992;28:201-14.

Porter ML, Dennis BL. Hyperbilirubinemia in the Term

Newborn. Am Fam Physician 2002;65:599-606.

Aminullah A. Ikterus dan hiperbilirubinemia pada neonatus. Dalam: Markum AH, Ismael S, editor. Buku ajar

Ilmu Kesehatan Anak. Jakarta: FKUI; 1999. h. 313-7.

American Academy of Pediatrics, Provincial Committee

for Quality Improvement. Practice parameter: management of hyperbilirubinemia in the healthy term

newborn.Pediatrics 1994;94:558-65.

Gomella TL. Hyperbilirubinemia. Dalam: Gomella TL,

Cunningham MD, Eyal FG, Zenk KE, penyunting.

Neonatology management, procedures, on-call problems,

diseases and drugs. Edisi ke-5. New York: McGaw Hill;

h. 381-95.

Uhudiah U, Oktavia D. Pemberian terapi sinar

berdasarkan penilaian klinis pada neonatus dengan

hiperbilirubinemia. Dalam: Rusdidjas, Tjipta GD,

Dimyati Y, penyunting. Kongres Nasional VIII Perinasia

& Simposium Internasional. Medan: Perinasia; 2003. h.

-81.

Indiarso F. Tranfusi tukar pada neonatus dengan

hiperbilirubinemia. Dalam: Rusdidjas, Tjipta GD,

Dimyati Y, penyunting. Kongres Nasional VIII Perinasia

& Simposium International. Medan: Perinasia; 2003. h.

-98.

Halamek LP, Stevenson DK. Neonatal jaundice and liver

disease. Dalam: Fanaroff AA, Martin RJ, penyunting.

Neonatal-perinatal medicine; Diseases of the fetus

and infant. 6th Ed. New York: Mosby-Year Book Inc;

h.1345-62.

Soorani-Lunsing I, Woltil HA, Hadders-Algra M. Are

moderate hyperbilirubinemia in healthy term neonate

really safe for the brain? Pediatr Res 2001;50:701-5.

Groen SE, Blecourt ACE, Postema K, Hadders-Algra M.

General movements in early infancy predict neuromotor

development at 9 to 12 years of age. Dev Med Child

Neurol 2005;43:731-8.

Bouwstra H, Dijk-Stigter GR, Grooten HMJ, JanssenPlas FEM, van Belle, Hadders-Algra M, dkkl. Prevalence

of abnormal general movements in three month old

infants. Early Hum Dev 2009;85:399-403.

Hadders-Algra M. Putative neural substrat of normal

and abnormal general movements. J Neubiorev

;31:1181-90.

De Graaf-Peters VB, Hadders-Algra M. Ontogeny of

the human central nervous system : what is happening

when? Early Hum Dev 2006;82:257-66.

Hansen TWR, Tommarello S, Allen JW. Subcelluler

Localization of bilirubin in rat brain after invivo iv

administration of [H] Bilirubin. Pediatric Research

;49:203-7.

Miller SP, Latal B, Clark H, Barnwell A, Glidden

D, Barkovich J, dkk. Clinical sign predict 30-month

neurodevelopmental outcome after neonatal encephalopathy. American J of Obstetr and Gynec

;190:93-9.

Moster D, Lie TR, Markestad T. Joint association of

Apgar scores and early neonatal symptoms with minor

disabilities at school age. Arch Dis Child Fetal Neonatal

;86:16-21.

Kliegman RM. Ikterus dan hiperbilirubinemia pada

bayi baru lahir. Dalam: Behrman, Kliegman, Arvin,

penyunting. Nelson Textbook of Pediatric. Edisi ke-15.

Philadelphia: WB Saunders Co; 2000. h. 610-16.

Shapiro SM. Bilirubin Toxicity in the Developing

Nervous System. Pediatric Neurology 2003;29:410-21.

Johnson MV, Hoon AH. Possible mechanism in infants

for selective basal ganglia damage from asphyxia,

kernicterus, or mitochondrial encephalopathies. J Child

Neurol 2000;15:588-91.

Groenendaal F, Grond J, Vries LS. Cerebral metabolism

in severe neonatal hyperbilirubinemia. Pediatrics

;114:291-4.

Soetomenggolo TS, Iman S. Kelainan toksik dan nutrisi.

Dalam: Soetomenggolo TS, Ismael S, penyunting. Buku

ajar Neurologi Anak. Edisi-2. Jakarta: BP IDAI; 2000.

h. 541-3.

Hadders-Algra M, Groothius AMC.Quality of general

movements in infancy is related to the development of

neurological dysfunction, attention deficit hyperactivity

disorder and aggressive behavior. Dev Med Child Neurol

;41:381-91.

Newman TB, Klebanoff MA. Neonatal hyperbilirubinemia and long-term out- come: another look at the

collaborative perinatal project. Pediatrics 1993;92:651-7.

Grimmer I, Berger-Jones K, Bührer C, Brandl U,

Obladen M. Late neurological sequela of non-hemolytic

hyperbilirubinemia of healthy term neonates. Acta

Paediatr 1999;88:661-3.

Maisels MJ, Newman TB. Predicting hyperbilirubinemia in newborns: the importance of timing. Pediatrics

;103:493-5.

Wu PYK, Hodgman JE, Kirkpatrick BV, White NB,

Phil M, Bryla DA. Metabolic aspects of phototherapy.

Pediatrics 1985;75(suppl):427-33.

Martinez JC, Maisels J, Otheguy L, Garcia H, Savorani

M, Mogni B, Martinez JC. Hyperbilirubinemia in the

breast-fed newborn: a controlled trial of four inter-

ventions.Pediatrics 1993;91:470-3.

Valaes T, Koliopoulos T, Koltsidopoulos A. The impact

of phototherapy in the management of neonatal

hyperbilirubinemia: a comparison of historical cohorts.

Acta Paediatr 1996;85:273-6 .

Amato M, Donati F Cerebral blood flow velocity in term infants treated with phototherapy. Brain Dev

;13:417-9.

Benders MJ, Van Bel F, Van de Bor M. Haemodynamic

consequences of phototherapy in term infants. Eur J

Pediatr 1999;158:323-8.

Tan KL, Skurr BA, Yip YY Phototherapy and the

brain-stem auditory evoked response in neonatal

hyperbilirubinemia. J Pediatr 1992;120:306-8.

Seidman DS, Paz I, Stevenson DK, Laor A, Danon

YL, Gale R The effect of phototherapy for neonatal

hyperbilirubinemia on long term cognitive performance.

Pediatr Res 1991;29:265A-7




DOI: http://dx.doi.org/10.14238/sp14.2.2012.122-9

Refbacks

  • Saat ini tidak ada refbacks.


##submission.copyrightStatement##

##submission.license.cc.by-nc-sa4.footer##

Informasi Editorial:
Badan Penerbit Ikatan Dokter Anak Indonesia
Jl. Salemba I No 5, Jakarta 10430, Indonesia
Phone/Fax: +62-21-3912577
Email: editorial [at] saripediatri.org

Lisensi Creative Commons
Sari Pediatri diterbitkan oleh Badan Penerbit Ikatan Dokter Anak Indonesia
Ciptaan disebarluaskan di bawah Lisensi Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional.